tiprankstipranks
Advertisement
Advertisement

CRBP Stock Latest News

Corbus Pharmaceuticals Appoints CMO Amid Key Trial Launches
Company AnnouncementsCorbus Pharmaceuticals Appoints CMO Amid Key Trial Launches
5d ago
8K
CRBP
Corbus Pharmaceuticals appoints Viana Nicacio as chief medical officer
PremiumThe Fly
Corbus Pharmaceuticals appoints Viana Nicacio as chief medical officer
5d ago
CRBP
Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho
18d ago
CRBP
Corbus Pharmaceuticals price target lowered to $52 from $54 at Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $52 from $54 at Oppenheimer
24d ago
CRBP
Corbus Pharmaceuticals management to meet with Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals management to meet with Oppenheimer
1M ago
CRBP
Corbus Pharmaceuticals price target lowered to $30 from $38 at Wedbush
PremiumThe FlyCorbus Pharmaceuticals price target lowered to $30 from $38 at Wedbush
2M ago
CRBP
Buy Rating Reaffirmed on CRB-701’s Emerging Efficacy and Undervalued Potential; $38 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on CRB-701’s Emerging Efficacy and Undervalued Potential; $38 Price Target Maintained
2M ago
CRBP
Corbus Pharmaceuticals share selloff overdone, says Guggenheim
Premium
The Fly
Corbus Pharmaceuticals share selloff overdone, says Guggenheim
2M ago
CRBP
Buy Rating Reiterated on CRB-701’s Best-in-Class Potential and De-Risked Path to Registrational Trial; $40 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on CRB-701’s Best-in-Class Potential and De-Risked Path to Registrational Trial; $40 Price Target Maintained
2M ago
CRBP
Corbus Highlights Promising CRB-701 Data in HPV Cancers
PremiumCompany Announcements
Corbus Highlights Promising CRB-701 Data in HPV Cancers
2M ago
8K
CRBP
Corbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data
PremiumThe Fly
Corbus Pharmaceuticals reports updated CRB-701 Phase 1/2 data
2M ago
CRBP
Corbus Pharmaceuticals price target raised to $44 from $40 at Mizuho
PremiumThe Fly
Corbus Pharmaceuticals price target raised to $44 from $40 at Mizuho
2M ago
CRBP
Corbus Pharmaceuticals Appoints First Chief Business Officer
PremiumCompany AnnouncementsCorbus Pharmaceuticals Appoints First Chief Business Officer
2M ago
8K
CRBP
Corbus Pharmaceuticals names Nishant Saxena as chief business officer
Premium
The Fly
Corbus Pharmaceuticals names Nishant Saxena as chief business officer
2M ago
CRBP
Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates
Premium
Company Announcements
Corbus Pharmaceuticals Adds Independent Director Amid Governance Updates
2M ago
8K
CRBP
Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential
PremiumRatings
Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential
2M ago
CRBP
Corbus Pharmaceuticals price target lowered to $54 from $57 at Oppenheimer
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $54 from $57 at Oppenheimer
2M ago
CRBP
Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies
PremiumThe Fly
Corbus Pharmaceuticals price target lowered to $33 from $36 at Jefferies
2M ago
CRBP
Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)
PremiumThe Fly
Corbus Pharmaceuticals reports Q1 EPS ($1.23), consensus ($1.22)
2M ago
CRBP
Corbus Highlights Oncology, Obesity Pipeline Progress and Outlook
PremiumCompany AnnouncementsCorbus Highlights Oncology, Obesity Pipeline Progress and Outlook
2M ago
8K
CRBP
MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts
Premium
Weekend Updates
MercadoLibre, T-Mobile, Corbus, Celestica, Elevance Trending With Analysts
2M ago
CLS
ELV
Spotify upgraded, Alibaba initiated: Wall Street’s top analyst calls
Premium
The Fly
Spotify upgraded, Alibaba initiated: Wall Street’s top analyst calls
2M ago
CLS
CNC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >